Established in 1997, and formerly known as ERBI, One Nucleus is a not-for-profit, membership organisation owned by its members and located in Cambridge and London – the centre of Europe’s leading life science and healthcare cluster.
More than 500 members include pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial service providers.
One Nucleus’s mission is to maximise the global competitiveness of our members. For our science and technology-based members, that means being global leaders in the research, development and commercialisation of healthcare innovations that radically improve the quality of people’s lives around the world. For our business and professional services members, it means delivering exceptional services that significantly enhance the business performance of their clients.
London and Cambridge
One Nucleus was formed in April 2010 by the merger of two regional lifescience networks – Cambridge-based ERBI and the London Biotechnology Network (LBN). Together we form a commercial, clinical and academic powerhouse. London and Cambridge are home to at least 60% of the UK’s life science industry base, four of the UK’s five Academic Health Science Centres and three of the world’s top six universities. The merger of ERBI and LBN recognises that the Cambridge-London network is an international life science “super cluster”.
The merger, driven by requests from ERBI and LBN members, results in several member benefits including:
- A large pool of companies to support business-to-business interaction
- Membership of a cluster of international size, relevance and visibility
- One membership providing discounted entry to events in London and Cambridge
- Economies of scale supporting our group purchasing scheme
- An expanded training programme focused on the needs of members